Nanovis, a Carmel, IN-based technology company selling nano-technology enhanced spinal implants, completed a $5.5m funding.
The round was managed by Commenda Securities, with participation from Elevate Ventures, 1st Source Capital Corporation, Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures.
The company intends to use the funds to meet increased working capital and sales needs from demand from surgeons and distributors for its nanotechnology enhanced spinal implants.
Led by CEO Matt Hedrick, Nanovis invents, acquires, and commercializes technologies that offer implants to reduce fixation and infection related complications. The company is commercializing science-driven platforms:
- the deeply porous scaffold currently available with the FortiCore® line of interbody fusion devices;
- an advanced nanotube-surface technology; and
- surface technologies with anti-colonization and bactericidal capabilities.